ARIX BIOSCIENCE PLC Holding(s) in Company

Transparency directive : regulatory news

22/06/2022 17:45

Arix Bioscience PLC (ARIX)
Holding(s) in Company

22-Jun-2022 / 16:45 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BD045071

Issuer Name

ARIX BIOSCIENCE PLC

UK or Non-UK Issuer

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Acacia Research Corporation

City of registered office (if applicable)

Country of registered office (if applicable)

4. Details of the shareholder

Name	City of registered office	Country of registered office
Merton Acquisition Holdco LLC	New York	United States

5. Date on which the threshold was crossed or reached

20-Jun-2022

6. Date on which Issuer notified

22-Jun-2022

7. Total positions of person(s) subject to the notification obligation

.	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	22.402098	0.000000	22.402098	28939210
Position of previous notification (if applicable)	21.042072	0.000000	21.042072

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BD045071	28939210		22.402098
Sub Total 8.A	28939210		22.402098%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Acacia Research Corporation	Merton Acquisition Holdco LLC	22.402098		22.402098%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Merton Acquisition Holdco LLC is a wholly-owned subsidiary of Acacia Research Corporation.

12. Date of Completion

22-Jun-2022

13. Place Of Completion

New York, New York, USA


ISIN:	GB00BD045071
Category Code:	HOL
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	2.3. Major shareholding notifications
Sequence No.:	170035
EQS News ID:	1381585


End of Announcement	EQS News Service

ARIX BIOSCIENCE PLC's latest news

12/02/2024 13:00

ARIX BIOSCIENCE PLC Holding(s) in Company

Transparency directive : regulatory news

ARIX BIOSCIENCE PLC's latest news

Other stories